BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9408217)

  • 1. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
    Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influencing the specificity of drug mixture discriminations by varying the training procedure.
    Stolerman IP; Mariathasan EA; White JA
    Behav Pharmacol; 1999 Nov; 10(6-7):657-64. PubMed ID: 10780507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitatory and inhibitory actions of morphine on the discriminative stimulus properties of D-amphetamine.
    Gaiardi M; Bartoletti M; Gubellini C
    Pharmacol Res; 1998 Nov; 38(5):333-7. PubMed ID: 9806811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of a visual reinforcer by D-amphetamine and nicotine in adult rats: relation to habituation and food restriction.
    Wright JM; Ren S; Constantin A; Clarke PBS
    Psychopharmacology (Berl); 2018 Mar; 235(3):803-814. PubMed ID: 29199358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
    Dukat M; Wesolowska A; Young R; Glennon RA
    Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AND and AND-OR drug mixture discriminations in rats: generalization to single drugs and drug mixtures.
    Mariathasan EA; Stolerman IP; White JA
    Psychopharmacology (Berl); 1999 Mar; 143(1):54-63. PubMed ID: 10227080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus properties of nicotine, amphetamine, and chlordiazepoxide as positive features in a pavlovian appetitive discrimination task in rats.
    Palmatier MI; Wilkinson JL; Metschke DM; Bevins RA
    Neuropsychopharmacology; 2005 Apr; 30(4):731-41. PubMed ID: 15592350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.
    Reichel CM; Murray JE; Barr JD; Bevins RA
    Neuropharmacology; 2010 Jun; 58(8):1237-45. PubMed ID: 20302882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.
    Mechanic JA; Wasielewski JA; Carl KL; Holloway FA
    Pharmacol Biochem Behav; 2002 Jul; 72(4):767-77. PubMed ID: 12062565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
    Kollins SH; Rush CR
    Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats.
    Desai RI; Barber DJ; Terry P
    Psychopharmacology (Berl); 2003 Jun; 167(4):335-43. PubMed ID: 12684733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine.
    Desai RI; Barber DJ; Terry P
    Behav Pharmacol; 1999 Nov; 10(6-7):647-56. PubMed ID: 10780506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats.
    Bevins RA; Klebaur JE; Bardo MT
    Behav Pharmacol; 1997 Jun; 8(2-3):113-23. PubMed ID: 9833007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discrimination analysis of pseudoephedrine in rats.
    Tongjaroenbuangam W; Meksuriyen D; Govitrapong P; Kotchabhakdi N; Baldwin BA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):505-10. PubMed ID: 9477001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats.
    Pittenger ST; Zeplin LC; Dwoskin LP; Bevins RA
    Psychopharmacology (Berl); 2015 Dec; 232(23):4347-58. PubMed ID: 26364957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the discriminative stimulus effects of nicotine function concurrently as modulatory opponents in operant and pavlovian occasion setting paradigms in rats?
    Troisi JR; Michaud NL
    Behav Processes; 2019 Jan; 158():144-150. PubMed ID: 30445119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental modulation of the interoceptive effects of amphetamine in the rat.
    Paolone G; Palopoli M; Marrone MC; Nencini P; Badiani A
    Behav Brain Res; 2004 Jun; 152(1):149-55. PubMed ID: 15135978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.